title: Prostate carcinoma.
abstract: Over the last several years, the development of prostate-specific antigen (PSA) testing and technical refinements of anatomic radical prostatectomy have revolutionized the care of patients with prostate cancer. Serum PSA testing often allows early diagnosis of organ-confined prostate cancer. Anatomical radical prostatectomy has a high probability of completely eradicating these tumors, with minimal long-term morbidity. Use of PSA testing after therapy confirms the long-term ability of surgery to eradicate early-stage prostate cancer.
authors.affiliation: Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.
authors.forename: G L
authors.initials: GL
authors.lastname: Andriole
authors.forename: W J
authors.initials: WJ
authors.lastname: Catalona
mesh_terms: D002277:Carcinoma / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000601:surgery; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D010808:Physical Examination; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000601:surgery; D012007:Rectum; D014463:Ultrasonography
chemical_list: D017430:Prostate-Specific Antigen